Skip to content

Terms of use

Terms of use

Welcome to TEDcom.be, a patient education platform dedicated to sharing information and resources on Thyroid Eye Disease (TED) and connecting patients through community initiatives. By using this website, you agree to these terms of use. Please read them carefully.

1. Purpose of the website

TEDcom.be is an educational initiative created by Esperity BV, with financial support from Amgen Belgium, and in collaboration with expert patients.

The site provides general information on dysthyroid orbitopathy (DOD). Its aim is to strengthen the knowledge of patients, their families and the general public, and to foster links with peer support communities.

⚠️ This website is not a substitute for professional medical advice, diagnosis or treatment. For all personal medical questions, always consult a qualified healthcare professional.

2. Using the content

All text, graphics, images and other elements available on this site are provided for information and educational purposes only.

  • You may download or share content for personal, non-commercial use, provided you respect the source and context.

  • Any modification, reproduction or distribution for commercial purposes without the prior written consent of Esperity is strictly prohibited.

3. Community links

TEDcom.be may include links to external resources, such as the Facebook community dedicated to TED.

  • These communities are moderated by expert patients but are not managed by Esperity.

  • Esperity cannot be held responsible for the accuracy of information shared on external platforms or for interactions between their members.

  • Users are encouraged to respect the rules of each community and the privacy of other members.

4. Privacy & Data Protection (RGPD Compliance)

We are committed to protecting your personal data in accordance with the General Data Protection Regulation (GDPR – EU 2016/679).

Data collected: The site does not require registration. If you contact us (e.g. via info@esperity.com), we may collect your name, e-mail address and the information you choose to provide.

Purpose of processing: Your data will only be used to respond to your request or provide the information requested.

Legal basis: Your consent (when you give it) or legitimate interest (responding to your request).

Retention period: Personal data is kept only as long as is necessary for communication purposes, unless the law requires longer retention.

Data sharing: We do not sell or share your data with third parties. In rare cases, service providers working for Esperity may have access to limited data subject to strict confidentiality agreements.

Your rights:

  • Access your data

  • Request correction or deletion

  • Limit or object to their processing

  • Withdraw your consent at any time

  • File a complaint with your national Data Protection Authority (DPA)

To exercise your rights: info@esperity.com. For more details, please also consult our Privacy Policy.

5. Limitation of liability

TEDcom.be provides its information “as is”, without warranty as to completeness, accuracy or fitness for a particular purpose.

Esperity, Amgen Belgium and the contributors shall not be liable for any damages arising out of the use or inability to use this site, including any reliance placed on its content.

Users remain solely responsible for their own health decisions and are strongly encouraged to consult healthcare professionals.

6. Modifications to these conditions

We may update these terms of use at any time. Updates will be posted on this page with the date of the last update. Continued use of the site after modification constitutes acceptance of the new conditions.

7. Contact details

If you have any questions about these conditions or the use of your data, please contact us:

Esperity BV Brussels, Belgium

info@esperity.com www.esperity.com

Esperity – Inspiring patients to achieve a better quality of life Esperity.com helps patients share their experiences, find support and access reliable health information via a secure digital platform.